Suppr超能文献

丙戊酸诱发的罕见X因子缺乏症病例。

A rare case of factor X deficiency induced by valproic acid.

作者信息

Rigon Pierre-Antonin, Ernest Vincent

机构信息

Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Hôpital Conception, Centre de Néphrologie et Transplantation Rénale, Marseille, France.

Laboratoire d'Hématologie, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

出版信息

Res Pract Thromb Haemost. 2025 Mar 3;9(2):102721. doi: 10.1016/j.rpth.2025.102721. eCollection 2025 Feb.

Abstract

BACKGROUND

Factor X (FX) deficiency (FXD) significantly disrupts coagulation, potentially leading to severe bleeding. While inherited FXD is rare, with a prevalence of 1 in 500,000, acquired FXD is also uncommon and frequently linked to conditions such as light-chain amyloidosis. In rare cases, certain medications can cause FXD.

KEY CLINICAL QUESTION

Here, we present a rare case of acquired FXD induced by valproic acid (VPA). This deficiency is associated with the presence of anti-FX antibodies.

CLINICAL APPROACH

A 65-year-old man undergoing treatment for various conditions, including chronic kidney disease and type 2 diabetes, developed severe FXD (activity <2 U/L) following VPA administration for epilepsy. During FXD, the patient experienced significant bleeding episodes, necessitating FX replacement with prothrombin complex concentrate. Upon discontinuation of VPA, FX activity improved in 9 days, possibly suggesting a role of the drug in FXD. Interestingly, antibodies directed against FX have been identified.

CONCLUSION

This case emphasizes the necessity for clinicians to be vigilant of hemostasis disorders associated with VPA, even though such occurrences are rare.

摘要

背景

凝血因子X(FX)缺乏症(FXD)会严重破坏凝血功能,可能导致严重出血。虽然遗传性FXD很罕见,患病率为五十万分之一,但获得性FXD也不常见,且常与轻链淀粉样变等疾病相关。在罕见情况下,某些药物可导致FXD。

关键临床问题

在此,我们报告一例由丙戊酸(VPA)诱发的罕见获得性FXD病例。这种缺乏与抗FX抗体的存在有关。

临床处理方法

一名65岁男性正在接受包括慢性肾病和2型糖尿病在内的多种疾病治疗,在接受VPA治疗癫痫后出现严重FXD(活性<2 U/L)。在FXD期间,患者经历了严重的出血事件,需要用凝血酶原复合物浓缩物替代FX。停用VPA后,FX活性在9天内有所改善,这可能表明该药物在FXD中起作用。有趣的是,已发现针对FX的抗体。

结论

该病例强调,尽管此类情况罕见,但临床医生仍需警惕与VPA相关的止血障碍。

相似文献

1
A rare case of factor X deficiency induced by valproic acid.
Res Pract Thromb Haemost. 2025 Mar 3;9(2):102721. doi: 10.1016/j.rpth.2025.102721. eCollection 2025 Feb.
3
Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency.
J Thromb Haemost. 2020 Oct;18(10):2551-2556. doi: 10.1111/jth.14985. Epub 2020 Jul 30.
4
Factor X deficiency and intracranial bleeding: who is at risk?
Haemophilia. 2011 Sep;17(5):759-63. doi: 10.1111/j.1365-2516.2011.02591.x. Epub 2011 Jun 20.
6
Occurrence and management of severe bleeding episodes in patients with hereditary factor X deficiency.
Haemophilia. 2021 Jul;27(4):531-543. doi: 10.1111/hae.14223. Epub 2021 May 22.
10
Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency.
Hematol Rep. 2025 Feb 21;17(2):10. doi: 10.3390/hematolrep17020010.

本文引用的文献

2
Acquired hemophilia A induced by clopidogrel.
Panminerva Med. 2024 Sep;66(3):347-349. doi: 10.23736/S0031-0808.23.05023-1. Epub 2023 Nov 30.
4
Factor X inhibitors: A seldom seen but important antibody mediated process.
Haemophilia. 2023 Sep;29(5):1175. doi: 10.1111/hae.14852. Epub 2023 Aug 30.
5
Clinical features and laboratory diagnostic issues of non-immune, non-amyloid related acquired factor X deficiency.
Haemophilia. 2023 Jul;29(4):1150-1154. doi: 10.1111/hae.14798. Epub 2023 May 17.
6
Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database.
Haemophilia. 2023 Jan;29(1):186-192. doi: 10.1111/hae.14692. Epub 2022 Nov 11.
7
Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study.
PLoS One. 2022 Feb 25;17(2):e0264351. doi: 10.1371/journal.pone.0264351. eCollection 2022.
8
Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency.
Blood Rev. 2021 Nov;50:100833. doi: 10.1016/j.blre.2021.100833. Epub 2021 Apr 27.
9
Autoimmune Coagulation Factor X Deficiency as a Rare Acquired Hemorrhagic Disorder: A Literature Review.
Thromb Haemost. 2022 Mar;122(3):320-328. doi: 10.1055/a-1496-8527. Epub 2021 Jun 15.
10
Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics.
J Thromb Thrombolysis. 2021 Aug;52(2):383-390. doi: 10.1007/s11239-021-02456-w. Epub 2021 Apr 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验